Merrimack's CEO, CFO and president abandon ship after canning clinical pipeline; uBiome overhauls management, again, amid FBI probe; and cue the "revolving door" criticism, as Gottlieb joins Pfizer’s board. Those moves plus more hirings, firings and retirings throughout the industry.